Baidu (NASDAQ: BIDU) and UAE partner AutoGo launched a fully autonomous commercial ride-hailing service on Yas Island, Abu Dhabi, available via the AutoGo app on Jan 17, 2026.The partners secured a fully driverless commercial permit in mid-November 2025 and signed a next-phase agreement to scale to hundreds of vehicles by 2026, with phased expansion planned to Reem, Al Maryah, and Saadiyat Islands and a long-term goal to cover the wider emirate.Apollo Go cites >240 million autonomous kilometers (over 140 million in fully driverless mode), 22 cities of presence, >17 million cumulative rides, and a weekly ride run-rate above 250,000.

Micron Technology, Inc. (Nasdaq: MU) today announced it has signed an exclusive Letter of Intent (LOI) to acquire Powerchip Semiconductor Manufacturing Corporation’s (PSMC) P5

NEW YORK and NEW ORLEANS, Jan. 16, 2026

{"summary":"","positive":[],"negative":[],"faq":[]}

ComEd today presented to the Illinois Commerce Commission its second multi-year grid plan containing ComEd’ s plans for critical investments to the grid in years 2028-2031. The plan builds upon the energy company’ s previous plan to strengthen the grid to continue delivering safe and affordable electric service and nation-leading reliability for ComEd’ s...

Organon, a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration has approved a supplemental New Drug Application for NEXPLANON ®, which is indicated for use by women of reproductive potential to prevent pregnancy. The sNDA extends the...

Black Titan (NASDAQ:BTTC) announced on January 16, 2026 that it entered a securities purchase agreement with a U.S.-based institutional investor for a convertible note financing facility of up to $200 million. The company said the committed capital will advance its DAT+ strategy—focused on digital asset utility, risk management, liquidity, and institutional operational readiness—and provide financial flexibility to accelerate platform development, strengthen the balance sheet, and pursue strategic partnerships and expansion. ARC Group Securities LLC acted as exclusive placement agent for the transaction.

New Era Energy & Digital (Nasdaq: NUAI) completed its acquisition of Sharon AI’s 50% ownership interest in Texas Critical Data Centers LLC (TCDC) on Jan 17, 2026. Sharon AI will retain no ownership, governance rights, or control provisions in TCDC. The company said the transaction moves TCDC from planning into execution and cited advisors Vinson & Elkins and Sheppard Mullin as legal counsel to the respective parties.Key points: New Era now holds 100% of TCDC, ending the joint ownership with Sharon AI and positioning the project for the next development stage.

CN (TSX: CNR; NYSE: CNI) responded to the Surface Transportation Board’s decision rejecting the Union Pacific–Norfolk Southern (UP–NS) merger application as incomplete on Jan 16, 2026. CN said UP and NS did not provide required information and that the filing is "missing the last mile," preventing a full public-interest and competition assessment under the new merger rules. CN urged customers to file notices of intent to participate and said it looks forward to robust participation once a complete application is submitted. CN also thanked the STB members and staff for a thorough review.

DBV Technologies (NASDAQ:DBVT) announced €166.7 million of gross proceeds from the full exercise of ABSA Warrants and BS Warrants issued in its March 2025 financing, resulting in issuance of 59,657,507 new shares and 71,005,656 second pre-funded warrants.Proceeds, together with existing cash, are intended to fund working capital, preparation/submission of a potential BLA and launch readiness for VIASKIN Peanut in children 4–7 in the U.S., if approved. The company estimates these funds support operations for at least 12 months and sees no substantial doubt about going concern as of the press release date.

Carriage Services (NYSE: CSV) announced executive promotions and appointments effective Feb 2, 2026, aligned with its 2030 Vision and long-term growth strategy. Steve Metzger is promoted to President & Chief Operating Officer overseeing Operations, Sales, Marketing, and M&A. Rene Negrete joins as Vice President of Operations; Sam A. Mazzu, III is promoted to Vice President, General Counsel and Secretary; Christine Ngo to Vice President of Human Resources; and Alfred White to Vice President of Marketing. CFO John Enwright gains expanded oversight of Information Technology and Supply Chain. The company said these changes support three strategic objectives: Purposeful Growth, Relentless Improvement, and Empowered Partnership, and aim to scale operations while reinforcing culture and service delivery.

The Board of Trustees of Source Capital, today announced that for the Fund’ s Discount Management Program measurement period from January 1, 2025 through December 31, 2025, the Fund traded at an average discount to net asset value of less than 10%. In fact, the Fund traded at a premium during the fourth quarter, peaking at a premium to NAV of 1.20% on November 28,...

Designation further supports- Endoxifen program into rare pediatric neuromuscular disease along with previously received Rare Pediatric Disease Designation. SEATTLE, Jan. 16, 2026/ PRNewswire/-- Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today...

Cellyan Biotechnology (Nasdaq: HKPD) received a Nasdaq notice dated Jan 12, 2026 that its closing bid price was below the $1.00 minimum for 30 consecutive business days (Nov 26, 2025–Jan 9, 2026), resulting in noncompliance with Nasdaq rule 5550(a)(2).The company’s listing remains active and trading is uninterrupted. Cellyan has a 180-calendar-day cure period until July 13, 2026 to regain a $1.00 closing bid for 10 consecutive business days or seek a second 180-day period by meeting other Capital Market listing standards and notifying Nasdaq.

Innovation Beverage Group (Nasdaq: IBG) received a Nasdaq notice dated January 14, 2026, for failure to hold an annual shareholder meeting within twelve months after fiscal year-end December 31, 2024, citing noncompliance with Nasdaq Listing Rules 5620(a), 5810(c)(2)(G), and IM-5620. The company has 45 calendar days to submit a compliance plan and stated it intends to submit a plan and hold an annual meeting by March 31, 2026. If Nasdaq accepts the plan, Nasdaq may grant an exception of up to 180 calendar days from the fiscal year end to regain compliance.

NusaTrip (Nasdaq: NUTR) announced that its IPO underwriter, Cathay Securities, has consented to an early release of Society Pass (Nasdaq: SOPA) from its six-month lock-up covering NusaTrip securities. NusaTrip completed its initial public offering in August 2025, and the underwriter's consent for the lock-up waiver to Society Pass became effective January 15, 2026. The lock-up originally restricted Society Pass from offering, selling, pledging or otherwise transferring NusaTrip securities for six months from the IPO commencement date, subject to exceptions.

AAM (NYSE: AXL) and Dowlais announced that the China State Administration for Market Regulation has issued a formal notice approving their recommended cash-and-share Combination, meaning all regulatory and antitrust approval conditions are now satisfied.The Combination still requires the Court to sanction the Scheme at a hearing on 30 January 2026, delivery of the Court Order to the Registrar of Companies, and satisfaction or waiver of any remaining Scheme conditions. The Scheme is expected to become effective on 3 February 2026. The AAM prospectus for the Secondary Listing is expected to be published shortly after the Court Hearing.

Turbo Energy (Nasdaq: TURB) received a Nasdaq notice dated January 12, 2026, saying the company is not in compliance with Nasdaq Capital Market listing rules because reported stockholders' equity of ~$1.5 million as of June 30, 2025 is below the $2.5 million minimum under Rule 5550(b)(1). Nasdaq also found Turbo Energy did not meet alternative standards for market value or net income. The Notice does not affect trading. Turbo Energy has until February 26, 2026 to submit a compliance plan and may request up to a 180-day extension if Nasdaq accepts the plan.The company is evaluating options to regain compliance while pursuing revenue growth, balance-sheet strengthening and international expansion, but there is no assurance Nasdaq will accept its plan.

First Western Trust (NYSE:MYFW) unveiled Adularia, an original digital art commission by local artist Chris Coleman, installed in the bank’s updated Boulder office on January 16, 2026. The immersive animation blends photogrammetry and video from more than a dozen Boulder-area trails to create 3D landscape models that explore memory, movement, and nature. The commission followed a 2023 nationwide search led by curator Simon Zalkind, which reviewed 20+ artists and shortlisted three finalists. The bank cites longstanding regional arts support since 2006.

A2Z Cust2Mate Solutions (NASDAQ: AZ) received a Nasdaq notification on Jan 13, 2026 for failure to hold an annual shareholder meeting within 12 months of its fiscal year end, citing noncompliance with Nasdaq Listing Rules 5620(a) and 5810(c)(2)(G). The company expects to consult with Nasdaq and currently anticipates holding the annual meeting on March 31, 2026. The company must submit a plan to regain compliance within 45 calendar days. If Nasdaq accepts the plan and meeting date, an exception of up to 180 days from the fiscal year end may be granted, potentially extending compliance until June 29, 2026. The Nasdaq notice does not have any immediate effect on the listing or trading of the company's securities.

Metallus (NYSE: MTUS) and United Steelworkers Local 1123 reached a tentative four-year contract agreement on Jan 16, 2026 covering about 1,200 bargaining employees at Metallus' Canton, Ohio operations.The new tentative deal follows member rejections of prior proposals on Oct 30 and Dec 18, 2025. The union will set the date for the next ratification vote. To allow time for member communication, the existing labor contract was extended 14 days until Feb 12, 2026. Operations will continue as normal during the extension.

New Jersey American Water (NYSE: AWK) filed for new rates on Jan 16, 2026 to support more than $1.4 billion of water and wastewater investments through December 2026. The request would fund nearly 120 miles of replacement/rehabilitation work, ongoing lead service line replacements, and investments to address emerging contaminants such as PFAS. If approved, the typical residential water customer would pay about $10 more per month and sanitary wastewater customers about $8 more per month. The filing also seeks approval to expand monthly bill discounts tied to LIHEAP/USF recipients and to pass back a Gross Receipts Tax refund to customers. The BPU review process, including public hearings, can take nine months or more and all rate changes require BPU approval.

This compares to a five dollar ninety-five cents per Unit distribution declared for the same period last year. The Trustees’ announcement today of a twenty-six cents per Unit distribution, as compared to the five dollar ninety-five cents per Unit distribution announced by the Trust at the same time last year, primarily reflects the Trustees’ decision a year...

Corvus Pharmaceuticals (NASDAQ: CRVS) will report results from cohort 4 of its randomized, blinded, placebo-controlled Phase 1 trial of soquelitinib in moderate to severe atopic dermatitis on Tuesday, January 20, 2026 at 8:00 am ET (5:00 am PT).The company will host a conference call and live webcast with presentation slides; domestic dial-in is 1-800-717-1738 and international is 1-646-307-1865. The live webcast and slides are available via Corvus investor relations, and a replay will be available on the website for 60 days.

Telix (TLX) announced the first U.S. patient has been dosed in BiPASS, a Phase 3 trial evaluating Illuccix and Gozellix 68Ga-PSMA-11 PET agents in the pre-biopsy prostate cancer diagnosis setting. The prospective, open-label study will enroll 250 patients across the U.S. and Australia and is designed to support marketing authorization for 68Ga-PSMA-PET in the pre-biopsy pathway. The trial will assess whether combining MRI with 68Ga-PSMA-11 PET improves diagnostic accuracy, reduces unnecessary biopsies (up to 75% of U.S. biopsies are reportedly negative), and enables better patient stratification and biopsy precision if objectives are met.